Annual Non Current Assets
$847.18 M
-$6.93 M-0.81%
31 December 2023
Summary:
Alnylam Pharmaceuticals annual long term assets is currently $847.18 million, with the most recent change of -$6.93 million (-0.81%) on 31 December 2023. During the last 3 years, it has risen by +$54.90 million (+6.93%). ALNY annual non current assets is now -0.81% below its all-time high of $854.11 million, reached on 31 December 2022.ALNY Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Non Current Assets
$849.62 M
+$12.84 M+1.53%
30 September 2024
Summary:
Alnylam Pharmaceuticals quarterly long term assets is currently $849.62 million, with the most recent change of +$12.84 million (+1.53%) on 30 September 2024. Over the past year, it has dropped by -$4.01 million (-0.47%). ALNY quarterly non current assets is now -33.89% below its all-time high of $1.29 billion, reached on 31 March 2021.ALNY Quarterly Non Current Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ALNY Non Current Assets Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -0.8% | -0.5% |
| 3 y3 years | +6.9% | +6.6% |
| 5 y5 years | +126.5% | +31.9% |
ALNY Non Current Assets High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -0.8% | +6.9% | -3.3% | +6.6% |
| 5 y | 5 years | -0.8% | +126.5% | -33.9% | +31.9% |
| alltime | all time | -0.8% | >+9999.0% | -33.9% | +7628.0% |
Alnylam Pharmaceuticals Non Current Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $849.62 M(+1.5%) |
| June 2024 | - | $836.78 M(+0.1%) |
| Mar 2024 | - | $835.78 M(-1.3%) |
| Dec 2023 | $2.98 B(+10.8%) | $847.18 M(-0.8%) |
| Sept 2023 | - | $853.62 M(-2.8%) |
| June 2023 | - | $878.35 M(+3.2%) |
| Mar 2023 | - | $850.92 M(-0.4%) |
| Dec 2022 | $2.69 B(-4.1%) | $854.11 M(+1.1%) |
| Sept 2022 | - | $844.41 M(-1.7%) |
| June 2022 | - | $858.78 M(+1.8%) |
| Mar 2022 | - | $843.87 M(+1.1%) |
| Dec 2021 | $2.81 B(+7.4%) | $834.73 M(+4.7%) |
| Sept 2021 | - | $796.95 M(+1.6%) |
| June 2021 | - | $784.27 M(-39.0%) |
| Mar 2021 | - | $1.29 B(+62.2%) |
| Dec 2020 | $2.61 B(+52.4%) | $792.28 M(-36.7%) |
| Sept 2020 | - | $1.25 B(+3.2%) |
| June 2020 | - | $1.21 B(+74.7%) |
| Mar 2020 | - | $694.85 M(+2.3%) |
| Dec 2019 | $1.72 B(+42.9%) | $679.27 M(+5.4%) |
| Sept 2019 | - | $644.36 M(-1.3%) |
| June 2019 | - | $652.64 M(+4.9%) |
| Mar 2019 | - | $621.99 M(+66.3%) |
| Dec 2018 | $1.20 B(-32.0%) | $374.11 M(+12.2%) |
| Sept 2018 | - | $333.53 M(+16.3%) |
| June 2018 | - | $286.83 M(+20.6%) |
| Mar 2018 | - | $237.84 M(+3.4%) |
| Dec 2017 | $1.76 B(+162.7%) | $229.99 M(-37.0%) |
| Sept 2017 | - | $364.91 M(-22.9%) |
| June 2017 | - | $473.57 M(-11.8%) |
| Mar 2017 | - | $536.74 M(-9.2%) |
| Dec 2016 | $671.88 M(-39.2%) | $590.93 M(+4.5%) |
| Sept 2016 | - | $565.35 M(+14.4%) |
| June 2016 | - | $494.09 M(+85.1%) |
| Mar 2016 | - | $266.88 M(-5.1%) |
| Dec 2015 | $1.11 B(+48.1%) | $281.12 M(-28.7%) |
| Sept 2015 | - | $394.35 M(-21.4%) |
| June 2015 | - | $501.62 M(-6.9%) |
| Mar 2015 | - | $538.60 M(+61.6%) |
| Dec 2014 | $746.37 M | $333.23 M(-2.9%) |
| Sept 2014 | - | $343.34 M(-6.6%) |
| June 2014 | - | $367.54 M(-9.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2014 | - | $406.23 M(+144.0%) |
| Dec 2013 | $254.03 M(+102.3%) | $166.50 M(-33.0%) |
| Sept 2013 | - | $248.34 M(+0.1%) |
| June 2013 | - | $248.20 M(+7.2%) |
| Mar 2013 | - | $231.47 M(+42.9%) |
| Dec 2012 | $125.56 M(-17.4%) | $161.96 M(+87.4%) |
| Sept 2012 | - | $86.42 M(+10.6%) |
| June 2012 | - | $78.14 M(-40.7%) |
| Mar 2012 | - | $131.76 M(+1.4%) |
| Dec 2011 | $152.03 M(-40.2%) | $129.89 M(-0.3%) |
| Sept 2011 | - | $130.27 M(+11.8%) |
| June 2011 | - | $116.49 M(-1.6%) |
| Mar 2011 | - | $118.34 M(-14.9%) |
| Dec 2010 | $254.14 M(-13.4%) | $139.13 M(-17.2%) |
| Sept 2010 | - | $167.98 M(+0.8%) |
| June 2010 | - | $166.67 M(-12.3%) |
| Mar 2010 | - | $190.10 M(+1.2%) |
| Dec 2009 | $293.53 M(-33.8%) | $187.85 M(-29.8%) |
| Sept 2009 | - | $267.50 M(+11.4%) |
| June 2009 | - | $240.23 M(+77.7%) |
| Mar 2009 | - | $135.19 M(+21.2%) |
| Dec 2008 | $443.12 M(+11.4%) | $111.55 M(-13.1%) |
| Sept 2008 | - | $128.40 M(+336.5%) |
| June 2008 | - | $29.41 M(-4.4%) |
| Mar 2008 | - | $30.78 M(-67.9%) |
| Dec 2007 | $397.90 M(+78.6%) | $95.89 M(+249.2%) |
| Sept 2007 | - | $27.46 M(+55.1%) |
| June 2007 | - | $17.70 M(+1.6%) |
| Mar 2007 | - | $17.42 M(+1.2%) |
| Dec 2006 | $222.78 M(+170.3%) | $17.22 M(-2.7%) |
| Sept 2006 | - | $17.70 M(-2.0%) |
| June 2006 | - | $18.06 M(+9.0%) |
| Mar 2006 | - | $16.57 M(+4.0%) |
| Dec 2005 | $82.41 M(+71.1%) | $15.93 M(-3.7%) |
| Sept 2005 | - | $16.55 M(-2.8%) |
| June 2005 | - | $17.02 M(-3.4%) |
| Mar 2005 | - | $17.63 M(-1.7%) |
| Dec 2004 | $48.18 M(+99.2%) | $17.93 M(+16.8%) |
| Sept 2004 | - | $15.35 M(-14.6%) |
| June 2004 | - | $17.96 M(+7.2%) |
| Mar 2004 | - | $16.75 M(+52.4%) |
| Dec 2003 | $24.19 M(+55.9%) | $10.99 M |
| Dec 2002 | $15.52 M | - |
FAQ
- What is Alnylam Pharmaceuticals annual long term assets?
- What is the all time high annual non current assets for Alnylam Pharmaceuticals?
- What is Alnylam Pharmaceuticals annual non current assets year-on-year change?
- What is Alnylam Pharmaceuticals quarterly long term assets?
- What is the all time high quarterly non current assets for Alnylam Pharmaceuticals?
- What is Alnylam Pharmaceuticals quarterly non current assets year-on-year change?
What is Alnylam Pharmaceuticals annual long term assets?
The current annual non current assets of ALNY is $847.18 M
What is the all time high annual non current assets for Alnylam Pharmaceuticals?
Alnylam Pharmaceuticals all-time high annual long term assets is $854.11 M
What is Alnylam Pharmaceuticals annual non current assets year-on-year change?
Over the past year, ALNY annual long term assets has changed by -$6.93 M (-0.81%)
What is Alnylam Pharmaceuticals quarterly long term assets?
The current quarterly non current assets of ALNY is $849.62 M
What is the all time high quarterly non current assets for Alnylam Pharmaceuticals?
Alnylam Pharmaceuticals all-time high quarterly long term assets is $1.29 B
What is Alnylam Pharmaceuticals quarterly non current assets year-on-year change?
Over the past year, ALNY quarterly long term assets has changed by -$4.01 M (-0.47%)